Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
Damar Hamlin was released from a Buffalo hospital and will continue to recover at home, just 10 days after the Bills player collapsed on the field and suffered a cardiac arrest.
British officials and space scientists said Tuesday they were disappointed but not deterred after the first attempt to launch satellites into orbit from the U.K. ended in failure.
